PHLT — Performant Healthcare Income Statement
0.000.00%
- $188.72m
- $187.43m
- $122.98m
- 54
- 49
- 48
- 49
Annual income statement for Performant Healthcare, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 156 | 124 | 109 | 114 | 123 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 170 | 126 | 116 | 120 | 132 |
Operating Profit | -14 | -1.32 | -6.9 | -6.13 | -9.5 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -21.2 | -10.2 | -6.41 | -7.86 | -10.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | -14 | -10.3 | -6.54 | -7.52 | -9.89 |
Net Income Before Extraordinary Items | |||||
Net Income | -14 | -10.3 | -6.54 | -7.52 | -9.89 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -14 | -10.3 | -6.54 | -7.52 | -9.89 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.07 | -0.14 | -0.097 | -0.096 | -0.122 |